chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SEVERE PAIN IN LUMBAR REGION OF SPINE; HEADACHE-3 DAYS; SEVERE SCIATIC NERVE PAIN IN LOWER LEFT LEG AND CONTINUING GOING DOWN THE KNEE WITH A LOT OF PAIN; This spontaneous report received from a patient concerned an 86 year old female. The patient's weight was 175 pounds, and height was 161.29 centimeters. The patient's concurrent conditions included herniated disk, non smoker, non-alcohol user, diabetic type 2, high blood pressure (HBP), arthritis spine, penicillin allergy, bee sting allergy, ragweed allergy, juniper allergy, strawberry allergy, grape allergy, asthma, and chronic pain, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient was not ill at time of vaccination, had no previous history of similar events and had not experienced any adverse events after previous vaccinations. The patient did not have acute illness 30 days prior to vaccination and hospitalization in last 30 days. Patient had no family history of any disease or allergy related to vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 11:15 upper left arm for prophylactic vaccination. Concomitant medications included nebivolol hydrochloride for high blood pressure, hydrocodone for pain, and metformin non-company for type 2 diabetes. On 09-MAR-2021, the subject experienced severe sciatic nerve pain in lower left leg and continuing going down the knee with a lot of pain. On 09-MAR-2021, the subject experienced headache-3 days. On 09-MAR-2021 21:00, the subject experienced severe pain in lumbar region of spine. On 10-MAR-2021, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe sciatic nerve pain in lower left leg and continuing going down the knee with a lot of pain, and severe pain in lumbar region of spine on 23-MAR-2021, and headache-3 days on MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210322279.
On 12/24/2020 started developing severe headaches with dizziness. On 12/27/2020 started getting chills, muscle aches, got covid tested (negative). On 12/29/2020 face and eyes started to swell, another covid test (negative). Continuous chills, sweats. Took tylenol, motrin, and benadryl around the clock. 01/02/2020 scratchy throat, more difficult to swallow, started on prednisone.
PATIENT SEEMED TO HAVE PROFOUND HEARING LOSS FOR 2 DAYS AFTER HER VACCINATIONS.  SHE DID NOT RESPOND TO HER NAME OR HER MOTHER'S VOICE.  SHE DID NOT STARTLE TO LOUD NOISES.
I began to feel COVID-like symptoms approximately 1.5w post dose #1: fatigue, cough, runny nose, congestion, mild sore throat x 8 days total. Additionally immediately fter dose 1, I felt moderate fatigue for 5 days and body aches and felt cold. My temperature stayed at 96 deg. which is below my usual. This resolved after 5 days until the previously mentioned illness.
Immediate runny nose with post nasal drip took a Claritin.  Then random quick dizzy spells, tongue slightly tingly on sides.  Took of mask and face was red with 1 hive under chin relieved with cool wash cloth.  Then adrenaline surge like I drank 5 expressos... trembling, palpitations. Last my lungs felt rattly.  I tgen went to ER and received benadryl
Myalgia, Fever, NauseaVomiting, INJECTION SITE PAIN Narrative: Other Relevant History
After receiving the Prevnar and 4 days prior received Rotavirus, the patient developed an urticarial looking rash at the lateral aspect of the leg where he received the vaccine. He also developed the same urticarial rash at the rest of the lateral aspect of the leg and no other places in the body. The rash did not resolved with Benadryl. He has no fever and the rash however does no seem to be pruritic. i have never seen a reaction that is not cellulitis  only on one leg if it is allergic. Could you tell me if this is expected with Prevnar?
Patient experienced lightheadedness, extreme fatigue, headache and body aches after first dose. Patient denies fever. First dose Pfizer lot #EK 9231 given on 1/7/2021. Patient received monoclonal antibody on 12/30/2020 according to Epic. However answered "have you had MAB therapy in the past 90 days? NO" in consent form. CDC recommends vaccine should be deferred 90 days after receiving MAB.
3/23/2023 My throat started feeling a little scratchy, I assumed it was allergies.  I felt fine that next morning. That evening my throat began feeling scratchy again. I was very restless after going to bed.  It was the first cold symptoms I had in years, so I knew it was something.  On 3/25/23, I got up and tested positive with an At Home COVID test.  I had a telehealth appointment on 3/27/23 and was prescribed a medication that I never picked up because I was feeling better by then.  I tested negative on 3/31/23 with an at home COVID test.
a pt recv vax 30sep98 & 5nov98 & following the 1st vax the pt exp a little bit itching over body & tenderness @ inject site. following 2nd pt exp a few headaches. no further info avail
Child received pediatric dose of Pfizer vaccine at 0.2ml. Child is 12 and should have received the full adult dose of Pfizer at 0.3ml. Patient's parent was notified of the error and educated on difference in vaccine doses based on age; family is aware patient will receive the full adult dose at 0.3ml when he returns for his second dose. No side effects occurred in the patient.
patient received vaccination same day symptoms started. symptoms started 2 hours later with intermittent dizziness and tingling sensation to R shoulder
a rash on her upper arm; itchiness that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination.     No Medical History Information was reported.  The patient's past medical history included Thyroid disorder since an unknown date.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of Cream and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included an unknown pill for a thyroid disorder daily. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination.     No Medical History Information was reported.  The patient's past medical history included Thyroid disorder since an unknown date.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of Cream and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included an unknown pill for a thyroid disorder daily.
Not at shot site, but below arm muscle, arm became very warm/hot and a rash developed.
Large red area in deltoid (entire deltoid) within 24 hours.  Benadryl anti inflammatory.
After the vaccine, a few days later , in the evening, my right leg felt sluggish / lazy.   The next morning visited ER clinic from there I was admitted with possible stroke.  From there, I was admitted to Hospital.    MRI confirmed I had a mini-stroke.   Was recommended physical therapy for right leg and to take  80 mg  aspirin daily.    Was hospitalized from 03/27/21 to 03/29/2021
Second day after shot I became achy, dizzy & had no energy. My equilibrium was terrible. This went on for one week. Sick to my stomach also. Went to the doctor the 3 day. Had a hearing test, facial xray & found nothing that would make me feel that way.
Patient was given 0.25mcg of Moderna Bivalent Booster which is the wrong dose, patient was supposed to receive 0.5mcg.
Itching and inflammation at injection site.  Patient allergic to Benadryl, so gave loratidine 10mg.
Information has been received from a medical assistant concerning a 12 month old male who on 4/14/06 was vaccinated in the right leg with a first dose of MMR II/Varicella vaccine. (lot 652233/0844R). There was no concomitant illness at the time of vaccination. On 4/22/06, eight days after vaccination, the pt developed a fever and a rash on the trunk, extremities and face. Subsequently, the pt recovered. Additional information is not expected.
Parents concern about fever and febrile seizure and seen in ER - had CBC, labs, Rocephin & Cefdinir.
EXTREME FATIGUE DURING THE DAY CAUSING ME TO FALL ASLEEP FOR SEVERAL HOURS EVEN AFTER HAVING A FULL NIGHT OF SLEEP
Hard injection site; Sore injection site; fever; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 30th September 2019, the patient received Boostrix. On an unknown date, less than 2 weeks after receiving Boostrix, the patient experienced injection site pain, fever and injection site induration. On an unknown date, the outcome of the injection site pain and fever were recovered/resolved and the outcome of the injection site induration was unknown.   It was unknown if the reporter considered the injection site pain, fever and injection site induration to be related to Boostrix.  Additional details were provided as follows: The age at the vaccination was not reported. The healthcare professional stated that a patient received a dose of Boostrix last Monday and developed a hard, sore injection site and a fever that lasted for four days. The reporter did not consent to follow-up. The reporter declined to follow up, refused to provide any further information. The case has been linked to the case US2019183215, reported by same reporter.
At the time of the adverse event I was 12 weeks pregnant with my first pregnancy. Estimated due date is 08/15/2021. Sunday afternoon developed a mild headache, about 24 hours after my second vaccine dose. As the evening progressed the headache got worse and developed into a debilitating migraine type headache. I have a history of hormonal migraine headaches, I would get them monthly, 1 week before my period would start, but have not gotten any since becoming pregnant. Because I am pregnant, I can not take my usual migraine medicine, so I took a dose of Tylenol PM extra strength, applied an ice pack to my head and went to bed. The next morning when I woke up the headache was gone and I felt fine.
Within 12 hrs of taking 2nd oral dose of oral typhoid vacc, awoke with ankle, hand hives. Resolved within hours, has been recurring nightly since (10 nights +). Completed course of vaccine.
swollen lymph nodes on the left side of the neck; soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes on the left side of the neck) and VACCINATION SITE PAIN (soreness at the site of injection) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No significant historical event reported.).    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 04-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes on the left side of the neck) and VACCINATION SITE PAIN (soreness at the site of injection). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes on the left side of the neck) and VACCINATION SITE PAIN (soreness at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment was taken for the events with Tylenol and Lidocaine patches.
Patient came into pharmacy 6/24/18 asking about her reaction to the SHINGRIX. What she seemed to describe was a SIRVA and bursitis due to poor injection technique. She complained about swelling, limited arm/shoulder movement and pain. She went to the doctors to have it check out and the doctor told the patient to come to the pharmacy and ask about possible reactions to the vaccine. The patient's arm movement has returned to almost normal and most of the pain has subsided though it is still a bit tender.
Patient began to fell dizzy approximately 3 minutes post injection, then promptly fainted. Pt was laid down on exam table at which time he was noted to appear pale. Pt was at this time speaking and answered questions appropriately.
A 13 year-old-patient received moderna vaccine booster dose/Patient under the age of 18 received moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 13 year-old-patient received moderna vaccine booster dose/Patient under the age of 18 received moderna vaccine) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: pfizer (1st dose) on 13-May-2021 and pfizer (2nd dose) on 03-Jun-2021. Past adverse reactions to the above products included No adverse event with pfizer and pfizer.    On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 11-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 13 year-old-patient received moderna vaccine booster dose/Patient under the age of 18 received moderna vaccine). On 11-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 13 year-old-patient received moderna vaccine booster dose/Patient under the age of 18 received moderna vaccine) had resolved.            Patient of age 13 years old received primary series of Pfizer vaccine and then received Moderna booster dose.  No concomitant treatment was provided.  No treatment medication was provided.
Blurred vision,  itching lips, arms and tongue  Facility took vitals and gave me a dose of 25mg Benadryl
Information has been received from a nurse concerning a female patient who was vaccinated with a 0.5ml dose of HPV vaccine. Subsequently, the patient fainted. Unspecified medical attention was sought. A short time after vaccination, the patient recovered. No product quality complaint was involved. Additional information has been requested.
sick; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was due to receive second dose of Pfizer BioNTech Covid 19 the week before but was sick in the hospital 2 days before (unspecified date) and was prescribed antibiotics for 10 days. They were asking how long she can wait to receive the second dose. Outcome of the event was unknown.  Information about lot/batch number has been requested.
Arm hurt after vaccination, fever, fatigued, achy. Did a home test, then had a telehealth appt with PCP. Decided not to take Paxlovid. Tested positive for 13 days. Fully recovered now.
Meningococcal Menactra given at 11 am Aug 9 2005. That evening patient had chills and couldn't sleep most of night because of them. Woke up Aug 10 with headache which persisted until the evening. Intermittent chills and slept most of afternoon. Left side neck slight stiff. All symptoms dissipated/gone by morning of Aug 11.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Medium, Additional Details: patient was given the vaccine and was asked to stay 15 minutes for observation. About 5 minutes later, patient was experiencing profused sweating and vomitting. Pharmacist Hiep Ngo attended to the patient and oberved closely. Ambulance was called. Patient was given water and felt better. EMT arrived and BP was taken. BP was normal. Patient was offered to go to the hospital but declined. EMT left, pt left 45 min. later. Hiep followed up with phone call to pt 2 hrs later at home. She was ok.
Case number PHEH2014US024313, is an initial spontaneous report from a nurse received on 02 Dec 2014 and with a follow-up from a nurse received on 21 Jan 2015. This report refers to a 60-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 18 Nov 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration. No further information was provided. Follow-up from a nurse received on 21 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
This case was reported by a consumer and described the occurrence of general body pain in a female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced general body pain, fatigue and product supply issue. On an unknown date, the outcome of the general body pain, fatigue and product supply issue were unknown. It was unknown if the reporter considered the general body pain and fatigue to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Six month before the reporting date, the patient received a dose of SHINGRIX. The patient had body aches, fatigue and she was unable to get out of bed for a half day after the vaccination. The patient was asking when did the SHINGRIX vaccines would be shipped. There was no availability of the vaccine in their area that she had found for receiving the 2nd dose. This case has been linked to the US2018GSK162777, reported by the same reporter.
Numbness, tingling, paresthesis, paralysis, autonomic nervous system dysfunction, diagnosed with Guillain-Barre syndrome in July 1999 and then later changed to CIDP in October 1999.  Hospitalized from July 16th, 1999 until January 2000.  In physical therapy for 3 years.
Fever - up to 103 degrees. Next day - for about 6 hours chills. Rt arm "Very sore" - x 1 day resolving next day.
Symptoms (cough, body aches, sore throat) for COVID on 5-28, Positive for COVID 19 on 6-3-21 with NEAR abbott ID now.   Had monoclonial therapy on 6/3/21
severe system reaction: chills, hot flashes, aching in lips and shoulders; severe system reaction: chills, hot flashes, aching in lips and shoulders; severe system reaction: chills, hot flashes, aching in lips and shoulders; severe system reaction: chills, hot flashes, aching in lips and shoulders; This is a spontaneous report from a 71-year-old female contactable consumer (Patient) or other non-HCP.  A 71-years-old female received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was EL9269) via an unspecified route of administration, administered in Arm Right on 10Feb2021 (at 05:00) (age at the time of vaccination was 70-years-old), as DOSE 2, SINGLE dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Previously, the patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was EL9262) via an unspecified route of administration, administered in Arm Left on 20Jan2021 (at 17:00), as DOSE 1, SINGLE dose for COVID-19 immunization. On an unspecified date, the patient experienced severe system reaction: chills, hot flashes, aching in lips and shoulders. With the 2nd injection, the patient did not have a topical reaction, there was no lump or rash. However, had a severe systemic reaction: chills, hot flashes, aching in lips and shoulders. The aching only lasted for about 4 days and she slept a lot. The chills and hot flashes continued sporadically for about 6 weeks. The clinical outcome of events aching in lips and shoulders was resolved and other events was unknown.  No follow-up attempts are needed. No further information is expected.
ARM "SO SORE COULD NOT LIFT IT UP" FEVER HEADACHE AND "FELT FLUISH".
PAIN IN ARM OF VACCINATION (LEFT ARM) PROGRESSED TO THE POINT THAT PATIENT LOST CONSCIOUSNESS FROM PAIN AND EVACUATED BOWEL AND BLADDER. WAS TAKEN TO HOSPITAL BY AMBULANCE. HOSPITAL CLEARED PATIENT OF ANY CARDIAC CONDITIONS. CT OF HEAD SHOULDER AND ARM WERE NORMAL.
we all had this head toll/a rash; hives on the face that is itchy; hives on the face that is itchy; arm was sore; getting blotches on the face; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "we all had this head toll/a rash"; URTICARIA (non-serious), PRURITUS (non-serious), outcome "unknown" and all described as "hives on the face that is itchy"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was sore"; RASH MACULAR (non-serious), outcome "unknown", described as "getting blotches on the face". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.